IHC
The firm is expanding its lab capabilities and leveraging its test development reputation to form partnerships early in the drug development process.
Companies that built their business in tissue and blood-based DNA analyses are now exploring imaging technologies across a variety of fronts.
Roche Nabs FDA Approval for Ventana PD-L1 Test as CDx for Libtayo
The immunohistochemistry test is used to detect programmed death-ligand 1 protein in non-small cell lung carcinoma patients.
NeoGenomics, ImmunoGen Ink Testing Deal for Newly Approved Folate Receptor Drug
The pharma firm will cover the cost for eligible ovarian cancer patients to be tested using the companion diagnostic to its new drug Elahere.
Roche Nabs FDA Approval for Ventana Test as CDx for Elahere
The immunohistochemistry-based test detects the folate receptor 1 protein that is over-expressed in most ovarian cancers.
Aug 8, 2022